Roxbury Financial LLC Buys New Position in Danaher Co. (NYSE:DHR)

Roxbury Financial LLC bought a new stake in shares of Danaher Co. (NYSE:DHR) in the 4th quarter, Holdings Channel.com reports. The firm bought 173 shares of the conglomerate’s stock, valued at approximately $42,000.

Other large investors also recently added to or reduced their stakes in the company. Fort Pitt Capital Group LLC grew its position in Danaher by 3.2% during the third quarter. Fort Pitt Capital Group LLC now owns 238,092 shares of the conglomerate’s stock valued at $66,194,000 after buying an additional 7,421 shares during the period. Good Life Advisors LLC bought a new position in shares of Danaher in the third quarter worth approximately $217,000. ORG Partners LLC boosted its position in shares of Danaher by 1,212.8% in the fourth quarter. ORG Partners LLC now owns 2,770 shares of the conglomerate’s stock worth $636,000 after purchasing an additional 2,559 shares during the period. Harvest Portfolios Group Inc. boosted its position in shares of Danaher by 1.2% in the third quarter. Harvest Portfolios Group Inc. now owns 202,263 shares of the conglomerate’s stock worth $56,233,000 after purchasing an additional 2,465 shares during the period. Finally, Generate Investment Management Ltd bought a new position in shares of Danaher in the fourth quarter worth approximately $8,044,000. 79.05% of the stock is currently owned by institutional investors.

Danaher Price Performance

Danaher stock opened at $206.66 on Friday. The company has a market cap of $149.26 billion, a price-to-earnings ratio of 39.14, a PEG ratio of 2.68 and a beta of 0.83. The firm’s fifty day moving average is $229.53 and its 200 day moving average is $249.51. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31. Danaher Co. has a 52-week low of $196.80 and a 52-week high of $281.70.

Danaher (NYSE:DHR) last released its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same quarter in the prior year, the business earned $2.09 EPS. Sell-side analysts forecast that Danaher Co. will post 7.67 EPS for the current fiscal year.

Danaher Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, January 31st. Shareholders of record on Friday, December 27th were given a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a yield of 0.52%. The ex-dividend date was Friday, December 27th. Danaher’s dividend payout ratio (DPR) is 20.45%.

Insider Buying and Selling at Danaher

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of the business’s stock in a transaction on Thursday, January 30th. The shares were sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the transaction, the senior vice president now owns 20,230 shares in the company, valued at $4,534,149.90. The trade was a 21.98 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Company insiders own 11.10% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on DHR shares. Stifel Nicolaus upped their price target on shares of Danaher from $250.00 to $265.00 and gave the stock a “hold” rating in a research report on Wednesday, October 23rd. Scotiabank started coverage on shares of Danaher in a research report on Monday, December 23rd. They issued a “sector perform” rating and a $265.00 price target for the company. Jefferies Financial Group dropped their price target on shares of Danaher from $285.00 to $260.00 and set a “buy” rating for the company in a research report on Wednesday, January 29th. KeyCorp upped their price target on shares of Danaher from $290.00 to $310.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 23rd. Finally, TD Cowen boosted their target price on shares of Danaher from $310.00 to $315.00 and gave the stock a “buy” rating in a report on Wednesday, October 23rd. Seven analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $278.00.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.